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Abstract. 
 
An interaction of growth cone axonin-1 with 
the ﬂoor-plate NgCAM-related cell adhesion molecule 
(NrCAM) was shown to play a crucial role in commis-
sural axon guidance across the midline of the spinal 
cord. We now provide evidence that axonin-1 mediates 
a guidance signal without promoting axon elongation. 
In an in vitro assay, commissural axons grew preferen-
tially on stripes coated with a mixture of NrCAM and 
NgCAM. This preference was abolished in the presence 
of anti–axonin-1 antibodies without a decrease in neu-
rite length. Consistent with these ﬁndings, commissural 
axons in vivo only fail to extend along the longitudinal 
axis when both NrCAM and NgCAM interactions,
but not when axonin-1 and NrCAM or axonin-1 and
NgCAM interactions, are perturbed. Thus, we conclude 
that axonin-1 is involved in guidance of commissural 
axons without promoting their growth.
Key words: axon guidance • growth cone • neuronal 
cell adhesion molecules • immunoglobulin superfamily 
• signal transduction
 
Introduction
 
Growing axons find their target area by integrating posi-
tive and negative guidance cues along their trajectory. The
molecules serving as guidance cues are secreted from in-
termediate or final targets, or are displayed on the surface
of cells or in the extracellular matrix along the axons’
pathway. The guidance function of these molecules con-
sists of a diverse set of effects, ranging from promotion of
axon elongation to induction of growth cone collapse fol-
lowed by axonal retraction (Tessier-Lavigne and Good-
man, 1996). The complex pattern of axonal highways with
intersections and bifurcations is encoded by a wealth of
molecular cues mediating axon growth, fasciculation, and
guidance. Therefore, axon pathfinding can be seen as the
result of axon growth along these highways combined with
specific decisions at choice points (Stoeckli and Land-
messer, 1998).
A relatively well characterized choice point is the floor
plate, a triangular structure formed by specialized cells at
the ventral midline where commissural axons of the spinal
cord decide to cross. Commissural axons, located in the
dorsolateral area of the spinal cord, project ventromedi-
ally toward the floor plate because they are attracted by
netrin-1 (Kennedy et al., 1994; Serafini et al., 1994). To
cross the midline, the axons enter the floor plate. After
reaching the contralateral border, they turn rostrally, still
keeping contact with the floor plate (Bovolenta and Dodd,
1990). Growth across the floor plate is mediated by inter-
actions between cell adhesion molecules (CAMs)
 
1
 
 of the
Ig superfamily that are exposed on the surface of floor-
plate cells and the growth cones of commissural axons (for
review see Stoeckli and Landmesser, 1998). Axonin-1 is
expressed on commissural axons (Shiga and Oppenheim,
1991; Stoeckli and Landmesser, 1995), whereas NgCAM-
related cell adhesion molecule (NrCAM) is displayed on
floor-plate cells (Krushel et al., 1993; Moscoso and Sanes,
1995; Stoeckli and Landmesser, 1995). When antibodies
against axonin-1 or NrCAM were injected into the central
canal of the embryonic chicken spinal cord in vivo, com-
missural axons committed pathfinding errors (Stoeckli and
Landmesser, 1995). Instead of growing across the floor
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plate to join the contralateral longitudinal tract, a consid-
erable number of axons prematurely joined the ipsilateral
longitudinal tract. Because injections of anti–axonin-1 and
anti-NrCAM produced a similar pattern of pathfinding er-
rors in vivo, and because purified axonin-1 and NrCAM
bound each other in vitro (Suter et al., 1995), it was sug-
gested that a direct binding of the growth cone axonin-1
with floor-plate NrCAM was required for guiding commis-
sural axons across the floor plate. In the absence of axo-
nin-1 and NrCAM interactions, the ipsilateral longitudinal
tract obviously presented an alternative that had been
completely neglected in the unperturbed choice situation.
In the present study, we have focused in more detail on
the molecular and functional interaction of axonin-1 and
NrCAM and its impact on the choice of commissural ax-
ons to grow across the floor plate. Based on the ability of
axonin-1 to bind both NgCAM and NrCAM in vitro
(Kuhn et al., 1991; Suter et al., 1995), and based on the
strong expression of NrCAM on floor-plate cells and Ng-
CAM on axons of the ventral longitudinal tract (Shiga et
al., 1990; Shiga and Oppenheim, 1991), we speculated that
commissural axons at the floor-plate border choose be-
tween two pathways of growth-promoting molecules: an
NrCAM pathway across the floor plate and an NgCAM
pathway along the ipsilateral longitudinal tract. Normally,
commissural axons opt for the NrCAM pathway, and only
under experimental conditions, when the NrCAM path-
way is not accessible, the NgCAM pathway is chosen.
Therefore, we postulated that commissural growth cones
grow across the floor plate, because they prefer NrCAM
over NgCAM as a growth-promoting substratum. To test
this hypothesis, we used a stripe assay, in which the axons
emerging from explants of commissural neurons were
offered the choice to elongate either on NrCAM or on
NgCAM. To our surprise, the commissural axons showed
no preference, but grew equally well on NgCAM and
NrCAM substratum. However, a clear preference was ob-
served for a mixed NrCAM/NgCAM substratum that was
alternated with an NgCAM substratum. In the presence of
anti–axonin-1 antibodies, this preference was abolished.
Because the same anti–axonin-1 antibodies that blocked
the preference of commissural axons for the mixed sub-
stratum did not reduce neurite lengths on NrCAM,
NgCAM, or mixed NrCAM/NgCAM substratum, we con-
cluded that axonin-1 is important for axon guidance but
not for axon growth. Thus, guidance of commissural axons
across the floor plate is not achieved by selecting the most
potent growth-promoting substrate, but rather guidance
and growth are distinct functions mediated by Ig super-
family CAMs. In accordance with exhibiting distinct func-
tions, CAM–CAM interactions can differ in their topol-
ogy. Whereas the cis-interaction between axonin-1 and
NgCAM appears to be involved in fasciculation of com-
missural axons, a trans-interaction between axonin-1 and
NrCAM is essential for their guidance across the midline.
 
Materials and Methods
 
Choice Assay with Commissural Neuron Explants
 
Commissural neurons were dissected from the lumbosacral spinal cord of
chicken embryos at stage 19–20 (Hamburger and Hamilton, 1951) as de-
 
scribed previously by Stoeckli et al. (1997). The neurons were dissected
before they had established contact with the floor plate in vivo, and, thus,
the axons grown in culture corresponded to the first axons developed by
the commissural neurons, rather than to the regenerating axons. The stage
of the embryos used was critical since commissural neuron explants pre-
pared from embryos at stage 21 or later were no longer able to attach to
NrCAM, NgCAM, or mixed NrCAM/NgCAM substrata.
NrCAM and NgCAM were immunoaffinity-purified from brain
membranes of 14-d-old embryos using the mAbs 2B3-C8 against NrCAM
(de la Rosa et al., 1990; Kayyem et al., 1992a) and 12-I-14-E 311 against
NgCAM (Rathjen et al., 1987). The purity of NrCAM and NgCAM was
tested by SDS-PAGE and Western blotting. We found no traces of
NgCAM and axonin-1 in purified NrCAM, and purified NgCAM was free
of contamination by NrCAM or axonin-1 (data not shown).
Commissural neurons were grown in a netrin-1–containing serum-free
medium. Conditioned medium was obtained by growing netrin-1–secret-
ing 293-EBNA cells (provided by Drs. Christine Mirzayan and Marc Tes-
sier-Lavigne, Howard Hughes Medical Institute, University of California
San Francisco, San Francisco, CA) for 3 d in DME/F12 (Sigma Chemical
Co.) supplemented with 5 mg/ml Albumax (GIBCO BRL), 100 
 
m
 
g/ml
transferrin, 10 
 
m
 
g/ml insulin, 20 ng/ml triiodothyronine, 40 nM progester-
one, 200 ng/ml corticosterone, 200 
 
m
 
M putrescine, 60 nM sodium selenite,
1 mM sodium pyruvate, and 2 mM glutamine (all from Sigma Chemical
Co.). The conditioned medium was harvested, passed through a 0.22-
 
m
 
m
filter, and diluted one to one with freshly prepared DME/F12 with all the
supplements described above. For antibody perturbation experiments, the
medium was supplemented with 250 
 
m
 
g/ml rabbit anti–NrCAM Fab of
polyclonal serum R51, 250 
 
m
 
g/ml goat anti–NgCAM Fab of polyclonal se-
rum G4 (Kuhn et al., 1991), or 500 
 
m
 
g/ml goat anti–axonin-1 IgG of poly-
clonal serum G67. IgG and Fab were prepared as previously specified
(Stoeckli et al., 1991). In the presence of anti-NrCAM antibodies, only
very few explants successfully attached to the NrCAM substratum and
neurite growth was strongly inhibited (not shown). The same result was
obtained with anti-NgCAM antibodies on an NgCAM substratum. To
exclude cytotoxicity of the polyclonal antibodies used, we added anti-
NrCAM antibodies to cultures on NgCAM and vice versa. Under both
conditions, explants attached well, and no reduction of neurite length was
observed (not shown).
For the choice assay, stripes of different substrata were coated directly
onto tissue culture plastic (Nunc, Inc.) using a special silicone matrix (pro-
vided by Ulrike Binkle and Dr. Claudia A.O. Stuermer, Department of
Biology, University of Konstanz, Konstanz, Germany). The stripes were
prepared according to the procedure described by Vielmetter et al. (1990).
In brief, for the first stripes, 10 
 
m
 
g/ml immunoaffinity-purified NgCAM or
NrCAM was injected into the open channels of the matrix that was placed
onto the tissue culture plastic. After incubation for 1 h at 37
 
8
 
C, the injec-
tions were repeated. After another hour of incubation at 37
 
8
 
C, unbound
proteins were removed by rinsing the dishes twice with PBS. For alternat-
ing stripes of two different substrata, the remaining binding sites were sat-
urated with a blocking solution containing 5 mg/ml Albumax in PBS for 30
min at 37
 
8
 
C. This blocking step was omitted, when the second substratum
was coated uniformly. The blocking solution was exchanged twice for PBS
and the matrix was removed before the dish was incubated with the sec-
ond substratum (immunoaffinity-purified NrCAM or NgCAM, each 10 
 
m
 
g/
ml) for 2 h at 37
 
8
 
C. When alternating stripes of NrCAM and NgCAM
were coated, the order of coating could be changed without an effect on
the result. To minimize the volume of the medium, the area of the culture
dish used for the explants was limited by a grease ring (high vacuum
grease; Dow Corning) that was applied by using a 14-ml Falcon snap-cap
tube as a stamp. Commissural neuron explants were cultured for 40 h at
37
 
8
 
C before fixation in 2% formaldehyde and 0.05% glutaraldehyde. The
fixative was added directly to the culture medium as a concentrated solu-
tion. Fixation was at 37
 
8
 
C for 30 min. In all cultures, the coated stripes
were visualized by indirect immunofluorescence. The following antibodies
were used: for NrCAM, the polyclonal rabbit serum R51 or the mAb 2B3-
C8; and for NgCAM, the polyclonal rabbit serum R24 (Kuhn et al., 1991)
or the mAb 12-I-14-E 311. As secondary antibodies, we used FITC-conju-
gated goat anti–rabbit IgG (Cappel Laboratories; Organon Teknika) and
Cy3-conjugated donkey anti–mouse IgG (Jackson ImmunoResearch Lab-
oratories, Inc.).
 
Neurite Outgrowth Assay
 
For neurite outgrowth assays, explants of commissural neurons were
grown on 8-well LabTek Permanox slides (Nunc) coated with immunoaf- 
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finity-purified NrCAM, NgCAM, or mixed NrCAM/NgCAM (each 10 
 
m
 
g/
ml) for 2 h at 37
 
8
 
C and washed twice with PBS. Commissural neuron ex-
plants were cultured for 18 h at 37
 
8
 
C and fixed in 2% formaldehyde and
0.05% glutaraldehyde as described above. For quantitative analysis, the
longest (3–5) neurites of each explant were measured using an inverted
microscope equipped with phase-contrast optics and the image analysis
software NIH Image. For each condition, cultures of three independent
experiments were analyzed. Because the neurite lengths measured were
not significantly different (Kruskal-Wallis test; Stat View, version 4.51),
the results were pooled. The percentage of neurites longer than a given
length was plotted versus neurite length (Chang et al., 1987).
 
Quantification of Growth Cone Areas of
Commissural Axons
 
For quantification of the growth cone areas, single growth cones were
identified and measured using the NIH Image analysis software (version
1.61). At least three independent experiments were analyzed for each con-
dition. Because the values were not significantly different (Wilcoxon rank
sum test), the results of the experiments were pooled. The growth cone ar-
eas measured under different conditions were compared in the Splus sta-
tistics program.
 
In Vivo Perturbation of Axonin-1, NrCAM, and 
NgCAM Interactions
 
In vivo injections and analyses of commissural axon pathfinding were
done as described previously (Stoeckli and Landmesser, 1995). Small vol-
umes of solutions containing one or combinations of two or three different
antibodies (10 mg/ml each) were injected into the central canal of the de-
veloping spinal cord in ovo. Injections were repeated every 8 h between
stages 18 and 23, which is the time when commissural axons in the lum-
bosacral region project to the floor plate and cross the midline. The em-
bryos were killed between stage 25 and early 26. Commissural axon
growth and pathfinding behavior were analyzed in whole-mount prepara-
tions (open books) by injections of FastDiI (1,1
 
9
 
-dilinoleyl-3,3,3
 
9
 
,3
 
9
 
-tet-
ramethylindocarbocyanine, 4-chlorobenzenesulfonate; Molecular Probes,
Inc.) into the area of neuronal cell bodies.
 
Heterologous Expression of NrCAM in Myeloma Cells
 
For aggregation assays, NrCAM was expressed in the nonadherent cell
line J558L according to the protocol described earlier for the expression
of axonin-1 (Rader et al., 1993). The full-length cDNA of NrCAM was
constructed from three different PCR fragments using the following
primers: AB6F, 5
 
9
 
-AGTAGAGCTCGCCACC
 
ATG
 
ATGAAAGAGA-
AGAG-3
 
9
 
 (SacI underlined, start codon boldfaced); AB21B, 5
 
9
 
-CTT-
CTCCTGGTACCCATGAGAGTTC-3
 
9
 
; Nr-1F, 5
 
9
 
-TTCTCGAAGCTT-
CTTTGTGTTAAAGGG-3
 
9
 
 (HindIII underlined); and Nr-1B, 5
 
9
 
-
AGGGATCC
 
TTA
 
CACAAATGAATTCATGGCATTTAC-3
 
9
 
 (BamHI
underlined, termination codon boldfaced). The PCR fragments were li-
gated, using 175 bp from the AB6F-AB21B fragment (cut at the primer-
derived SacI and an internal XhoI site at position 196) and the 3,148-bp
fragment (Robert P. Lane; from XhoI [196] to HindIII [3,278] including
AS12 described by Kayyem et al. [1992b]). The 562-bp Nr1F-Nr1B frag-
ment was attached using the HindIII site (3,278) and the BamHI site of
the backward primer. The full-length cDNA was cloned into the vector
pCD4-FvCD3-c
 
k
 
 
 
(Traunecker et al., 1991), which was modified by intro-
ducing a multiple cloning site and the splice donor consensus sequence
GTAAGT between the SacI and the HindIII sites. Stable transfectants of
mouse myeloma cells J558L were obtained by protoplast fusion and selec-
tion with 
 
L
 
-histidinol (Rader et al., 1993). After 10 d, the cells were
screened for surface NrCAM by indirect immunofluorescence. Clones
with high NrCAM expression were expanded and subcloned.
 
Cell Aggregation Assay
 
CAM-expressing myeloma cells were labeled with different intracellular
fluorescent dyes to follow their aggregation pattern. For the aggregation
assay, we used the procedure described by Rader et al. (1993) with the fol-
lowing modifications: after 30 min at 37
 
8
 
C, the cells were fixed in a final
concentration of 2% formaldehyde and 0.05% glutaraldehyde for 30 min
at room temperature. To reduce the background, 1 M ethanolamine
(Fluka Chemie) in PBS, pH 7.4, was added to a final concentration of 50
mM. After incubation for 15–20 min at room temperature, freshly pre-
 
pared 1 M sodium borohydride (Sigma Chemical Co.) was added to a final
concentration of 45 mM, and the cells were incubated for 1 h at room tem-
perature. After centrifugation in v-shaped 96-well plates (Corning Costar
Corporation) for 3 min at 1,000 rpm in a Sorvall 6000D, the cells were re-
suspended in PBS, and examined with a fluorescence microscope (Leitz
DMRD; Leica Microsystems) using the G/R filter that allows simulta-
neous visualization of FITC and TRITC. For controls, the myeloma cells
were incubated with either 500 
 
m
 
g/ml rabbit anti-NrCAM Fab or goat–
anti–axonin-1 Fab during loading of the intracellular dyes. For quantita-
tive analysis, the total number of cells (at least 100) within the view field
of the microscope, the percentage of cell in aggregates, and the ratio of the
two cell types were determined. Results from at least nine independent
experiments were statistically analyzed.
 
Immunoblotting
 
Stably transfected myeloma cells expressing NrCAM or NgCAM were
washed twice with PBS and counted. Transiently transfected COS7 cells
were analyzed 2 d after electroporation. The cells were washed twice with
PBS, detached and dissociated by treatment with 2 mM EDTA in PBS,
and were counted. To solubilize the membrane proteins, the cells were
lysed in 1% (wt/vol) Triton X-100, 1% (wt/vol) CHAPS, 0.1% (wt/vol)
SDS, 5 mM EDTA, 1 mM PMSF, 1 mM iodoacetamide, 100 mM NaCl, and
in 50 mM Tris-HCl, pH 7.5. The solubilized proteins were precipitated ac-
cording to Wessel and Fluegge (1984) and resuspended in sample buffer.
After boiling for 5 min, the proteins were separated by SDS-PAGE and
transferred to a nitrocellulose membrane. The nitrocellulose was blocked
overnight in 1% (wt/vol) blocking reagent for chemiluminescence detec-
tion (Roche Diagnostics) in TBS and incubated for 2 h in 1% (wt/vol)
blocking reagent/TBS containing the primary antibody. For detection of
NrCAM and NgCAM in myeloma cells, the mAbs 2B3-C8 and 12-I-14-E
311, respectively, were used at a concentration of 10 
 
m
 
g/ml. For detection
of the NrCAM domain deletion mutants expressed in COS7 cells, the rab-
bit anti-NrCAM antiserum R51 was used at a dilution of 1:2,000. The im-
munoblots were rinsed thoroughly with TBS before incubation for 1 h in
0.5 
 
m
 
g/ml sheep anti–mouse Fab or sheep anti–rabbit IgG coupled to per-
oxidase in 0.5% (wt/vol) blocking reagent in TBS. The membranes were
rinsed again in TBS followed by 0.1% (wt/vol) Tween 20 in TBS. Protein
bands were detected with the chemiluminescence kit from Roche Diag-
nostics. For densitometric quantification, the Image QuaNT software
(version 4.1) from Molecular Dynamics was used.
 
Construction of NrCAM Domain Deletion Mutants
 
The domain deletion mutants of NrCAM were inserted downstream of
the cytomegaloviral promoter into the eucaryotic expression vector pSCT,
which we previously used for the expression of the domain deletion mu-
tants of axonin-1 and NgCAM (Buchstaller et al., 1996; Rader et al., 1996;
Kunz et al., 1998). Domain borders were chosen according to Grumet et
al. (1991). To construct the domain deletion mutants, three different plas-
mids were used as a template for PCR: pSCT NrCAM and pBluescript
NrCAM, both containing full-length cDNA of chicken NrCAM, and
pSP73-Ig1-Fn1 NrCAM (pSP73 from Promega Corporation), which in-
cluded a truncated form of the NrCAM cDNA coding for all Ig domains
and the first FnIII domain. Note that the cDNAs of NrCAM have been
cloned in reverse orientation into pBluescript NrCAM and pSP73-Ig1-Fn1
NrCAM plasmids.
The following primer sequences were used for construction of the do-
main deletion mutants of NrCAM. Bold letters show introduced restric-
tion sites and underlined letters represent mismatches: Ig1F, 5
 
9
 
TGG-
AGGTTGAGACAATTCTTCTAGAGT3
 
9
 
; Ig12B, 5
 
9
 
CCATCTAGAT-
CCCCTTTGTGGACTAAA3
 
9
 
;
 
 
 
Kpn1F, 5
 
9
 
TTGTAATGGGACTGTTAT-
TTTCTTCTCCTG3
 
9
 
; Ig2dB, 5
 
9
 
AAGCCAGTTACA
 
CGG/CCG
 
CCACC-
AGTTCTT3
 
9
 
 (EagI restriction site); Ig21F, 5
 
9
 
AGGGGATCTAGA
 
CGG/
CCG
 
TATAACAATATT3
 
9
 
 (EagI restriction site); Xba1B, 5
 
9
 
GCAGC-
TGAAGCTTGCATGCCTGCAGGTCGA3
 
9
 
; Ig23F (dIg34-back), 5
 
9
 
TTC-
TGTAACTGGCTTGGTTG3
 
9
 
; Ig34B, 5
 
9
 
TACTGGATAACAGCACCC-
AGGAACTTAG3
 
9
 
; Ig34F, 5
 
9
 
TGGGGCAGCTTTTACAGTTACCGA-
AAT3
 
9
 
; Ig45B (dIg34-for), 5
 
9
 
CCAAGGATTCTAACTCCTGC3
 
9
 
; Ig2/
3B, 5
 
9
 
AGGCCACCAGTTCTTCTTACACCAATGGGCAGC3
 
9
 
; Ig4/5F,
5
 
9
 
TGGCTCAGCAAGAACATTCACAAATGCATT3
 
9
 
; Ig6F1B, 5
 
9
 
CCA-
AATCCACCGCTTGACTTGGAATTGGAATTGACAGGT3
 
9
 
; Ig6-
FN1-5
 
9
 
, 5
 
9
 
GAACGC
 
GTCGAC
 
CAAATCCACCGCTTGAC3
 
9
 
 (SalI re-
striction site); BsaBI-3
 
9
 
, 5
 
9
 
ATCCCTTGTACATTAGAAGG3
 
9
 
; BglII-5
 
9
 
,
5
 
9
 
ACAGCCACAGTACAAAGTG3
 
9
 
; Ig6-FN1-3
 
9
 
, 5
 
9
 
ACAG
 
CTCGA- 
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G
 
CGTAAATGATAGCTG3
 
9
 
, (XhoI restriction site); FN5/TM-5
 
9
 
,
5
 
9
 
AGGA
 
CTCGAG
 
CAATGGCAAGTCGGCAG3
 
9
 
 (XhoI restriction
site); and Stop-Sal-3
 
9
 
, 5
 
9
 
TAGGGCGAATTGGGTACC3
 
9
 
.
For the construction of 
 
D
 
Ig1-6 NrCAM, the PCR fragment Ig6-FN1-5
 
9
 
-
BsaBI-3
 
9
 
 (from pSCT NrCAM as template) was cut with SalI-BsaBI and
ligated to the linkers 5
 
9
 
CTAG
 
AAGAATTGTCTCAACC3
 
9
 
 (XbaI over-
hang, sense) and 5
 
9
 
TCGA
 
GGTTGAGACAATTCTT3
 
9
 
 (SalI overhang,
antisense). The construct was introduced into the expression vector pSCT
NrCAM, which had been digested with XbaI-BsaBI. For the construction
of 
 
D
 
Fn1-5 NrCAM, the fragments BglII-5
 
9
 
-Ig6-FN1-3
 
9
 
 digested with
BglII-XhoI (from pSCT NrCAM) and FN5/TM-5
 
9
 
-Stop-Sal-3
 
9
 
 digested
with XhoI-SalI (from pBluescript NrCAM) were cloned into pBluescript
NrCAM, which had been cut with BglII-SalI. From this vector, an XbaI-
SalI fragment was cut and finally cloned into pSCT NrCAM, which was
cut with XbaI-SalI. 
 
D
 
Ig2 NrCAM was generated using a similar strategy.
The PCR fragment Kpn1F-Ig2dB (from pSCT NrCAM) was digested with
KpnI, treated with polynucleotide kinase, and cloned into pBluescript di-
gested with HincII. An HpaI-EagI fragment was excised from this vector
and, together with the PCR fragment Ig21F-Xba1B (from pSP73-Ig1-Fn1
NrCAM; digested with XbaI-EagI), was cloned into pSCT NrCAM, cut
with HpaI-XbaI. All other mutants were cloned using the plasmid linear-
ization method, which allows exact domain deletions without amino acid
exchanges, because the primers for PCR were matched to the domain bor-
ders. As a template for PCR amplifications, we used pSP73-Ig1-Fn1 Nr-
CAM, which was linearized using a restriction enzyme with a unique cut-
ting site within the domain to be deleted. For construction of 
 
D
 
Ig12,
pSP73-Ig1-Fn1 NrCAM was linearized with Bst1107I and the primers
Ig1F and Ig2/3B were used for PCR. After ligation and plasmid amplifica-
tion, an XbaI-BsmI fragment was cloned into pSCT NrCAM digested
with XbaI-BsmI. Using the same strategy 
 
D
 
Ig34 (primer pair, Ig23F and
Ig45B), 
 
D
 
Ig56 (Ig4/5F and Ig6F1B), 
 
D
 
Ig1 (Ig1F and Ig12B), 
 
D
 
Ig3 (Ig23F
and Ig 34B), and 
 
D
 
Ig4 (Ig34F and Ig45B) were generated.
All deletion mutants were verified by double strand DNA sequencing.
Based on the numbering of the amino acid sequence of NrCAM used by
Grumet et al. (1991), the following segments were deleted in the mutants:
 
D
 
Ig1-6 NrCAM, P17-A596; 
 
D
 
Fn1-5 NrCAM, P598-P1094; 
 
D
 
Ig12 NrCAM,
T18-E217; 
 
D
 
Ig34 NrCAM, R218-P405; 
 
D
 
Ig56 NrCAM, P406-R597; 
 
D
 
Ig1
NrCAM, T18-R111; 
 
D
 
Ig2 NrCAM, P112-E217; 
 
D
 
Ig3 NrCAM, R218-P313;
and 
 
D
 
Ig4 NrCAM, Y314-P405. The insertion of the XhoI site into the
 
D
 
Fn1-5 NrCAM resulted in a silent mutation of R597 (CGG-CGA). The
only mutation generated was R218 (AGG) to P218 (CGG) in 
 
D
 
Ig12 Nr-
CAM by the insertion of the EagI site.
 
Expression of NrCAM or Axonin-1 in COS7 Cells
 
The cDNAs of wild-type and mutant NrCAM or axonin-1 were cloned
into the expression vector pSCT and used for transient transfection of
COS7 cells according to Rols et al. (1994). In brief, 10
 
6
 
 COS7 cells were
collected by trypsinization and resuspended in 700 
 
m
 
l PBS. 10 
 
m
 
g vector
DNA purified with the EndoFree plasmid purification kit (QIAGEN
GmbH) was added in 100 
 
m
 
l PBS. The cells were incubated with the DNA
for 10 min on ice before electroporation in a 0.4-cm cuvette with a 960-
 
m
 
F/
230 V pulse in a Bio-Rad gene pulser (Bio-Rad Laboratories). After 9.5
min at 378C, the cells were plated in 60-mm cell culture dishes in DME
supplemented with 10% FCS. To remove dead cells and debris, the cul-
tures were washed twice with PBS after 8 h and grown for another 16 h in
10 ml DME supplemented with 10% FCS. This procedure resulted in suc-
cessful heterologous expression of NrCAM and axonin-1 in 20–30% of the
cells. According to the Western blot analysis, all Ig domain deletion mu-
tants were expressed at similar levels (see Fig. 9). The only mutant that
was found in lower amounts was DFn1-5 NrCAM. As axonin-1 binding of
this mutant was comparable to wild-type NrCAM, the lower expression
level did not negatively interfere with the purpose of the study. In sum-
mary, the Western blot analysis of the mutant NrCAM proteins revealed
the expected molecular masses and demonstrated that the mutant pro-
teins were present on the cells in similar concentrations.
Analysis of Protein–Protein Interactions Using 
Covaspheres and Transfected COS7 Cells
24 h after transfection, the COS7 cells were washed twice with PBS, har-
vested by treatment with 2 mM EDTA in PBS, and resuspended in DME
with 10% FCS. The cells were transferred to poly-L-lysine–coated glass
Lab-Tek slides (Nunc) and cultured for another 24 h. For the Cova-
spheres-binding assay, the FCS in the culture medium was exchanged for
5 mg/ml Albumax (GIBCO BRL). Axonin-1, NrCAM, and NgCAM were
coupled to TRITC- or FITC-labeled fluorescent polystyrene microspheres
(Covaspheres, nominal diam 0.5 mm; Duke Scientific Corp.) as described
elsewhere (Kuhn et al., 1991). Immediately before addition to the cells,
the Covaspheres were sonicated for 3 min. Transfected COS7 cells were
incubated with Covaspheres for 1 h at 378C. They were rinsed twice with
DME-Albumax and fixed with 2% formaldehyde for 1 h at 378C. After
washing twice with 1% FCS in PBS, COS7 cells were subjected to indirect
immunofluorescence staining. Wild-type and mutant NrCAM were visual-
ized with the polyclonal goat serum G68 and FITC-conjugated rabbit
anti–goat IgG (Zymed Laboratories Inc.). Polyclonal rabbit serum R26
and Texas red–conjugated donkey anti–rabbit IgG (Jackson ImmunoRe-
search Laboratories, Inc.) were used for detection of wild-type and mu-
tant axonin-1. For examination, we used a Leica microscope (Leitz
DMRD). For quantification, strongly fluorescent cells binding at least
four Covaspheres were scored as binding cells (nonexpressing cells were
found to bind 0–1 Covaspheres).
For antibody perturbation experiments, the cells were preincubated for
1 h with 30 mg/ml mAbs DIg1, NIg1, and X9H8 raised against axonin-1
(Rader et al., 1996). After rinsing three times with DME-Albumax (5 mg/
ml), the Covaspheres were added as described above. For detection of ax-
onin-1–expressing cells, we used a Cy3-conjugated donkey anti–mouse an-
tibody.
Results
Commissural Axons Prefer a Mixed NrCAM/NgCAM 
Substratum over NgCAM Alone
When commissural axons reach the border of the floor
plate in vivo, they choose to grow into the floor plate
rather than to follow the ipsilateral longitudinal tract.
Based on the results of perturbation studies in vivo
(Stoeckli and Landmesser, 1995) and because NgCAM is
highly expressed on axons of the longitudinal tract and Nr-
CAM is expressed on floor-plate cells, we speculated that
axonin-1–expressing commissural axons make their path-
way choice based on a preference for NrCAM over Ng-
CAM. To test this hypothesis, explants of commissural
neurons, characterized by their location within the spinal
cord, their responsiveness to netrin-1, and their expression
of axonin-1, were cultured on a substratum composed of
alternating stripes of NgCAM and NrCAM (for details see
Stoeckli and Landmesser, 1995; Stoeckli et al., 1997; see
also Materials and Methods). To our surprise, the commis-
sural axons did not show any substratum preference. The
axons elongated equally well on both NgCAM and NrCAM,
and no differences in axon and growth cone morphologies
were detectable (Fig. 1).
However, on close observation of these cultures, we
found that the filopodia of many growth cones were touch-
ing the border of two adjacent stripes of NrCAM and
NgCAM, thus contacting both substrata simultaneously.
Therefore, we offered axons a choice between a mixed
NrCAM/NgCAM substratum versus NgCAM or NrCAM
alone. A clear preference for the mixed NrCAM/NgCAM
substratum was seen when commissural axons were given
a choice between mixed NrCAM/NgCAM alternated with
stripes of NgCAM only (Fig. 2 a). In this situation, the ma-
jority of the growth cones was found on the stripes coated
with the NrCAM–NgCAM mixture, whereas only occa-
sionally a growth cone was found on an NgCAM stripe.
Furthermore, we found that the growth cones residing on
the preferred NrCAM/NgCAM stripes were considerably
larger than the growth cones growing on alternating stripes
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In contrast, when commissural axons were offered a
choice between mixed NrCAM/NgCAM substratum ver-
sus pure NrCAM substratum, the growth cones showed no
preference and grew randomly without respecting substra-
tum boundaries (Fig. 2 b). The fact that a preference for
the mixed NrCAM/NgCAM substratum concomitant with
growth cone enlargement was only seen when the alter-
native substratum was NgCAM, but not when it was
NrCAM, excluded a general preference for a composite
substratum. Therefore, we concluded that the response of
commissural axons in our assay reflected a specific choice.
The Preference of Commissural Axons for the Mixed 
NrCAM/NgCAM Substratum Depends on Axonin-1
Because previous studies demonstrated a crucial role of
axonin-1 and NrCAM interactions in the guidance of com-
missural axons across the floor plate (Stoeckli and Land-
messer, 1995; Stoeckli et al., 1997), we tested the effects of
anti–axonin-1 antibodies in our in vitro choice assay. Inter-
estingly, commissural explants cultured on alternating
stripes of NrCAM/NgCAM and NgCAM in the presence
of anti–axonin-1 antibodies no longer showed a preference
for the mixed substratum (Fig. 3 a). The growth cones
were randomly distributed over the entire surface, without
respecting substratum borders. They were considerably
smaller than those grown on the same substratum combi-
nation in the absence of anti–axonin-1 antibodies. For a
control, explants were cultured in the presence of anti-
NrCAM antibodies (Fig. 3 b). In this case, commissural
axons could no longer detect NrCAM in the mixed sub-
stratum, and, as expected, grew randomly. As seen in the
presence of anti–axonin-1, growth cones were small (Fig.
4). Thus, by either blocking axonin-1 on the growth cones
or NrCAM of the substratum, the preference response and
the enlargement of the growth cones were abolished.
Figure 1. Commissural ax-
ons show no preference for
plain NgCAM versus plain
NrCAM substratum. When
commissural explants were
cultured on alternating
stripes of purified NrCAM
and NgCAM, they grew ran-
domly across the stripes. The
number of growth cones seen
on the red and the green
stripes was about equal, indi-
cating that the growth cones
did not prefer either one of
the substrata. The order of
coating could be reversed
without an effect on the re-
sult (a and b). (a) NrCAM
was coated first (1. Nr), fol-
lowed by NgCAM (2. Ng).
(b) The order of coating was
reversed: NgCAM was
coated first (1. Ng) and
NrCAM second (2. Nr).
Stripes were visualized with
antibodies against NgCAM
(first row) and NrCAM (sec-
ond row). The third row
shows the explants with
phase-contrast optics.The Journal of Cell Biology, Volume 149, 2000 956
Enlarged Growth Cones Are only Observed in 
Conjunction with a Preference Response
Growth cones of the commissural axons on mixed Nr-
CAM/NgCAM substratum alternating with NgCAM were
markedly enlarged. Interestingly, growth cones remained
small on NrCAM/NgCAM when the alternating stripes
were NrCAM or on uniformly coated NrCAM/NgCAM
substratum. These observations suggested that the growth
cone enlargement and the preference response were con-
nected phenomena. As a first step in addressing this issue,
we measured the size of growth cones under eleven dis-
tinct conditions in at least three independent experiments.
For each experimental condition, at least 36 single growth
cones not contacting an axon or another growth cone
were measured with the NIH image analysis program.
The results confirmed the impression that only growth
cones exhibiting a preference response were significantly
enlarged (Fig. 4). Growth cones on mixed NrCAM/Ng-
CAM alternated with NgCAM substratum had an av-
erage surface area of 294 mm2, whereas, in all other
conditions, the average growth cone surface was below
145 mm2.
Figure 2. Commissural axons
prefer a mixed NrCAM/
NgCAM substratum over
NgCAM. (a) When commis-
sural axons were offered a
choice between stripes with a
mixture of NrCAM and Ng-
CAM (Nr/Ng) and stripes
with NgCAM (Ng) alone,
they clearly preferred the
mixed substratum. Growth
cones were almost exclu-
sively found on stripes of
mixed NrCAM/NgCAM sub-
stratum. Note that growth
cones were extremely large
compared with all other con-
ditions (Figs. 1, 2 b, and 3).
Although many growth
cones exhibited extended
contacts with the border,
very few were observed to
spread across the border and
establish contact with the
NgCAM substratum. The
pattern of radial outgrowth
and the few growth cones ob-
served on NgCAM indicate
that growth cones can cross
NgCAM stripes. This sug-
gests that the behavior of the
growth cones is based on a
preference-generating rather
than a repulsive effect. Note
that large growth cones ap-
pear black in the NgCAM
and NrCAM staining but can
be identified in phase-con-
trast optics. (b) In contrast,
when commissural axons
were offered a choice be-
tween stripes of mixed
NrCAM/NgCAM (Nr/Ng)
and stripes of NrCAM (Nr)
alone, they showed no pref-
erence for the mixed substra-
tum. Growth cones on both
types of stripes were smaller
than those in a. Substratum
stripes were visualized as in
Fig. 1.Fitzli et al. Distinct Signals for Axon Guidance and Growth 957
Neurite Growth on NrCAM, NgCAM, and Mixed 
NrCAM/NgCAM Substrata Is Comparable and Not 
Affected by Anti–axonin-1 Antibodies
To assess the contribution of the axonin-1/NrCAM inter-
action to neurite outgrowth promotion, we compared
neurite lengths on NrCAM, NgCAM, and the mixture of
NrCAM and NgCAM in the absence and in the presence
of anti–axonin-1 antibodies. As shown in Fig. 5 (a and b),
NrCAM, NgCAM, and mixed NrCAM/NgCAM were
equally potent in neurite outgrowth promotion. The addi-
tion of the same anti–axonin-1 antibodies that were used
in the choice assay did not interfere with neurite out-
growth on any substratum (Fig. 5, a and c–e). Therefore,
we concluded that the preference-mediating interaction
between growth cone axonin-1 and substratum NrCAM is
not involved in neurite growth promotion. And conse-
quently, the neurite growth-promoting effect of NrCAM
must be mediated by a growth cone receptor distinct from
axonin-1.
A Simultaneous Perturbation of NrCAM and NgCAM 
Interactions Blocks the Extension of Commissural 
Axons along the Longitudinal Axis In Vivo
We performed a series of in ovo experiments to test the
relevance of these in vitro results for commissural axon
pathfinding in vivo. A role for axonin-1 and NrCAM in
axon guidance was established earlier (Stoeckli and Land-
messer, 1995). In these in vivo studies, the perturbation of
axonin-1 interactions was shown to result in defascicula-
tion and pathfinding errors of commissural axons. Instead
of crossing the midline, axons turned into the longitudinal
axis prematurely along the ipsilateral floor-plate border.
Figure 3. The preference of
commissural axons for the
mixed NrCAM/NgCAM sub-
stratum is dependent on
growth cone axonin-1. (a)
The presence of anti–axo-
nin-1 antibodies in the cul-
ture medium completely
abolished the preference of
commissural axons for the
mixed NrCAM/NgCAM sub-
stratum (Nr/Ng) seen in the
absence of antibodies (com-
pare Fig. 2 a). Growth cones
grew randomly without re-
specting substratum bound-
aries. Note that the growth
cones are considerably
smaller than on the same
substratum combination in
the absence of antibodies
(Fig. 2 a). (b) As a control,
anti-NrCAM antibodies
were added to the medium of
the commissural explants. As
expected under these circum-
stances, NrCAM was no
longer detectable as a sub-
stratum component, result-
ing in random neurite
growth. Substratum stripes
were visualized as in Fig. 1.The Journal of Cell Biology, Volume 149, 2000 958
Similar pathfinding errors were found after perturbation
of NrCAM interactions. In contrast, the perturbation of
NgCAM interactions did not result in pathfinding errors.
Although commissural axons grew to the ventral border of
the spinal cord in a very defasciculated manner, they still
managed to cross the midline. Based on these results, a
model for commissural axon guidance was suggested in
which NgCAM was involved in fasciculation of commis-
sural axons both before and after crossing the midline.
NrCAM, expressed by the floor plate, was a binding part-
ner for growth cone axonin-1–mediating entrance and
crossing of the floor plate. Thus, axonin-1 was involved in
pathfinding and fasciculation of commissural axons, in line
with its potential to bind to both NrCAM and NgCAM in
vitro.
To follow up on the in vitro results described above, we
performed a new series of in vivo experiments, in which
we tried to sort out the functional contributions of NrCAM,
NgCAM, and axonin-1 to growth and guidance of commis-
sural axons. In particular, we wanted to test whether the
contributions of NrCAM and NgCAM were growth pro-
motion, whereas the role of axonin-1 was to select the
pathway. To find evidence for the growth-promoting activ-
ity of NrCAM and NgCAM, we injected combinations of
anti–axonin-1, anti-NrCAM, and anti-NgCAM antibodies
into the developing chicken spinal cord in ovo. Consistent
with the finding that both NrCAM and NgCAM can pro-
mote commissural axon growth in vitro (Fig. 5), a strong
effect on axon growth was found in vivo (Fig. 6). The si-
multaneous blockage of NrCAM and NgCAM interac-
tions resulted in the failure of the majority of commissural
axons to extend along the longitudinal axis (Fig. 6, a and
e). Many axons made it across the floor plate, and some
even turned, whereas others piled up at the ipsilateral bor-
der (Fig. 6 e). Similarly, when a cocktail of anti–axonin-1,
anti-NrCAM, and anti-NgCAM was injected, axons failed
to turn and extend along the longitudinal axis (Fig. 6, b
and f). However, due to the additional blockade of axonin-1
interactions, more axons stopped at the ipsilateral bor-
der, when all three antibodies were injected (Fig. 6 f). The
collapsed, clublike morphology of growth cones treated
with the cocktail of all three antibodies is in line with ob-
servations made in an earlier in vitro study, where growth
cones were found to collapse upon floor-plate contact in
the presence of anti–axonin-1 but not anti-NrCAM anti-
bodies (Stoeckli et al., 1997). Thus, the in vivo results
shown here support the hypothesis raised in an earlier
study (Stoeckli et al., 1997) that axonin-1 has at least one
additional binding partner on the floor plate that is distinct
from NrCAM.
When anti–axonin-1 antibodies were injected together
with either anti-NgCAM (Fig. 6 c) or anti-NrCAM anti-
bodies (Fig. 6 d), growth along the longitudinal axis was
not affected. The most likely explanation for these obser-
vations is the redundancy of the growth-promoting activi-
ties of NrCAM and NgCAM. When NrCAM is masked,
NgCAM takes over and vice versa. As seen in vitro (Fig.
5), the growth-promoting activities of NrCAM and Ng-
CAM were equivalent and each molecule stimulated axon
growth at the maximal level. The mixture of NrCAM and
NgCAM did not have an additive effect. Consistent with
results from earlier in vivo studies (Stoeckli and Land-
messer, 1995; Stoeckli et al., 1997), NrCAM also had an ef-
fect on axon guidance. When injected alone or in combina-
tion with anti-NgCAM antibodies, anti-NrCAM induced
pathfinding errors of some commissural axons. This effect
on pathfinding is mediated most likely by a direct interac-
tion with growth cone axonin-1, whereas the growth cone
receptor mediating axon growth is not yet identified. Thus,
although the situation in vivo is more complex than the sit-
uation mimicked in our in vitro stripe assay, the conclusion
drawn from the in vitro experiments is valid for the in vivo
situation. In both cases, axonin-1 is responsible for the
choice of the growth cone to grow along one but not the
other pathway/stripe without influencing axon extension,
because both in vivo and in vitro, the presence of anti–axo-
nin-1 antibodies did not reduce axon length.
Figure 4. The substratum preference of commissural axons coin-
cides with the enlargement of growth cones. Enlarged growth
cones were observed only in the choice situation, where commis-
sural axons clearly preferred mixed NrCAM/NgCAM over single
NgCAM substratum (Fig. 2 a). Surface areas of growth cones
were measured with the NIH Image analysis 1.61 software.
Growth cone areas were ,145 mm2 in all conditions, where no
preference was observed, such as alternating stripes of NrCAM
and NgCAM (first two bars). However, growth cones doubled in
size (x 5 294 6 34 mm2) when a choice for the mixed substratum
and against the NgCAM stripes was made. The same substratum
combination did not result in enlarged growth cones, when a
preference reaction was abolished by addition of either anti–axo-
nin-1 (fourth bar) or anti-NrCAM antibodies (fifth bar). The
combination of mixed NrCAM/NgCAM substratum with Nr-
CAM stripes did not elicit a preference correlated with small
growth cones (sixth and seventh bars). Accordingly, mixed Nr-
CAM/NgCAM substratum coated homogeneously without or
with anti–axonin-1 antibodies did not change growth cone size
(eighth and ninth bars). Growth cone areas were comparable on
homogeneous NrCAM (10th bar) and NgCAM (11th bar), re-
spectively. The number of growth cones analyzed for each condi-
tion is indicated in brackets. Three independent experiments
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The Direct Interaction of Axonin-1 with NrCAM Is
a Trans-Interaction
Based on the pathfinding errors of commissural axons
caused by injection of antibodies against axonin-1 and
NrCAM into the central canal of the spinal cord and based
on the expression pattern of axonin-1, expressed by
growth cones, and NrCAM, expressed by floor-plate cells,
a trans-interaction between the two molecules was sug-
gested (Stoeckli and Landmesser, 1995). A direct interac-
tion between axonin-1 and NrCAM has been described for
purified proteins covalently bound to fluorescent poly-
styrene beads (Covaspheres; Suter et al., 1995), but the to-
pology of the axonin-1/NrCAM binding (cis versus trans)
has not been investigated so far. A cis- rather than a trans-
interaction between axonin-1 and NgCAM had been
found to be involved in the growth of dorsal root gan-
glion neurites (Buchstaller et al., 1996; Kunz et al., 1996;
Stoeckli et al., 1996). The effect of both axonin-1 and Ng-
CAM on the fasciculation of commissural axons described
in an earlier in vivo study (Stoeckli and Landmesser, 1995)
is compatible with a cis-interaction between axonin-1 and
NgCAM also on commissural axons. However, the role of
axonin-1 and NrCAM in commissural axon pathfinding
would require a trans-interaction rather than a cis-interac-
Figure 5. Anti–axonin-1 anti-
bodies do not reduce neurite
length on NrCAM, NgCAM,
and mixed NrCAM/NgCAM
substrata. Commissural neu-
ron explants were cultured
on either NrCAM, NgCAM,
or mixed NrCAM/NgCAM
substrata in the presence or
absence of anti–axonin-1 an-
tibodies. After 18 h in cul-
ture, the explants were fixed
and neurite lengths were ana-
lyzed. (a) Representative ex-
amples of each experimental
condition are shown in
phase-contrast optics. No dif-
ferences in the length and the
morphology of the neurites
were observed. (b–e) The vi-
sual impression was con-
firmed by quantification of
neurite outgrowth. For each
experimental condition, at
least 20 explants were ana-
lyzed. Results of three inde-
pendent experiments were
pooled and plotted as the
percentage of neurites longer
than a given length versus
neurite length (see Materials
and Methods for details). (b)
The comparison of neurite
lengths on NrCAM (open cir-
cles), NgCAM (open trian-
gles), and mixed NrCAM/
NgCAM (open diamonds)
revealed equal neurite out-
growth-promoting activities
of all three substrata. The
presence of anti–axonin-1 an-
tibodies (filled symbols) in
the medium did not reduce
neurite length on NrCAM
(c), NgCAM (d), or mixed
NrCAM/NgCAM (e). Neu-
rite length in the absence of
anti–axonin-1 is indicated
with open symbols.The Journal of Cell Biology, Volume 149, 2000 960
tion. To confirm that the topology of the axonin-1/NrCAM
binding is different from the axonin-1/NgCAM binding,
we stained NrCAM- and axonin-1–expressing myeloma
cells with different fluorescent dyes and subjected them to
cell aggregation assays (Rader et al., 1993). Mixed aggregates
composed of approximately equal numbers of NrCAM-
and axonin-1–expressing myeloma cells were formed, indi-
cating a heterophilic trans-interaction of axonin-1 and
NrCAM (Fig. 7, a and f). The specificity of cell aggrega-
tion was tested in antibody perturbation experiments. In
the presence of either anti–axonin-1 Fab or anti–NrCAM
Fab, the percentage of cells in aggregates was significantly
reduced. In particular, the formation of mixed aggregates
was strongly decreased (not shown). In the presence of
anti–axonin-1 Fab, the remaining aggregates were mainly
homophilic NrCAM aggregates. Likewise, in the presence
of anti–NrCAM Fab, mainly homophilic axonin-1 aggre-
gates were found. In both cases, 10–14% of the cells in the
homophilic aggregates were of the other cell type, proba-
bly because of unspecific trapping of cells in aggregates.
This corresponds to the percentage of untransfected (i.e.,
wild-type) cells found incorporated in aggregates, when
these cells were mixed with NrCAM- or axonin-1–express-
ing cells, respectively (Fig. 7 f). The formation of homoge-
neous aggregates composed of NrCAM- (Fig. 7 b), axo-
nin-1– (Fig. 7 c), or NgCAM-expressing myeloma cells (Fig.
7 d) is consistent with previous reports on the homophilic
binding capacities of these molecules (Grumet and Edel-
man, 1988; Mauro et al., 1992; Rader et al., 1993; Buch-
staller et al., 1996). Therefore, these results demonstrate
Figure 6. Axonin-1 is important
for guidance, but not for elonga-
tion of commissural axons in vivo.
NrCAM and NgCAM provide
redundant outgrowth-promoting
signals for commissural axons.
Axonin-1 mediates axon guid-
ance across the floor plate. In
embryos treated with a combina-
tion of anti-NrCAM and anti-
NgCAM antibodies (a and e),
only a few axons managed to
elongate along the longitudinal
axis. Most axons were stuck at
the floor-plate border. Whereas
the majority made it across the
floor plate, some failed to be-
cause of the perturbation of
NrCAM interactions. The failure
to extend along the longitudinal
axis was also found in embryos
that were treated with a cocktail
of anti–axonin-1, anti-NrCAM,
and anti-NgCAM antibodies (b
and f). However, consistent with
the role of axonin-1 in commis-
sural axon guidance (Stoeckli
and Landmesser, 1995), the per-
turbation of axonin-1 interac-
tions resulted in a significant pro-
portion of commissural axons
that were unable to cross the
floor plate and, therefore, were
found to pile up at the ipsilateral
border. Axon elongation along
the longitudinal axis was not de-
creased when either NrCAM or
NgCAM could provide a growth-
promoting stimulus. Embryos injected with a combination of anti–axonin-1 and anti-NgCAM (c) or anti–axonin-1 and anti-NrCAM (d)
showed no reduction in axon elongation compared with control embryos (not shown). Because both anti–axonin-1 and anti-NrCAM an-
tibodies induced pathfinding errors (Stoeckli and Landmesser, 1995), more fibers were found to turn ipsilaterally in embryos treated
with anti–axonin-1 and anti-NrCAM (d) compared with embryos treated with anti–axonin-1 and anti-NgCAM (c). In line with time-
lapse observations in vitro (Stoeckli et al., 1997), commissural growth cones had a collapsed morphology at the floor-plate border (f, ar-
row). In contrast, growth cones had a complex morphology at the ipsilateral floor-plate border in the absence of anti–axonin-1 (e, ar-
rows). A difference in growth cone morphology was still observed at the contralateral border (e and f, arrowheads). Note that the
change in growth cone morphology is induced upon floor-plate contact only and not simply because of the presence of anti–axonin-1 an-
tibodies, as the growth cone marked with an asterisk in f does not have a collapsed, clublike morphology but exhibits several filopodia.
The floor plate is marked with dashed lines in all panels. The longitudinal axis runs vertically. Rostral is to the top, and caudal is to the
bottom of each panel. Bars: (a–d) 100 mm; (e–f) 50 mm.Fitzli et al. Distinct Signals for Axon Guidance and Growth 961
unequivocally that axonin-1 and NrCAM from different
cells bind each other and mediate cell–cell binding.
The strong heterophilic trans-interaction between NrCAM
and axonin-1 found in the present study is in contrast to
the absence of a trans-binding between NgCAM and axo-
nin-1 using the same system (Buchstaller et al., 1996).
Quantification of NrCAM and NgCAM expression in the
myeloma cells by Western blot analysis (Fig. 7 g) revealed
a sixfold higher expression level of NgCAM compared
with NrCAM. Thus, the absence of an axonin-1/NgCAM
trans-interaction cannot be explained by a lower expres-
sion of NgCAM compared with NrCAM, but reflects a dif-
ference of the two proteins in the topology of their binding
to axonin-1.
The Binding Site of Axonin-1 Is Localized on the Four 
NH2-Terminal Ig Domains of NrCAM
For a more detailed characterization of the axonin-1/NrCAM
trans-interaction, the NrCAM domains involved in axo-
nin-1 binding and the axonin-1 domains involved in NrCAM
binding were identified. For this purpose, domain deletion
mutants of both molecules were generated and expressed
in COS7 cells that were used for binding studies with axo-
nin-1- or NrCAM-conjugated fluorescent Covaspheres. Cells
expressing a heterologous protein on their surface were vi-
sualized by indirect immunofluorescence staining. 
To identify the domains of NrCAM that are involved in
the binding of axonin-1, several domain deletion mutants
of NrCAM were generated and expressed in COS7 cells
(Fig. 8 c). In the first step, an NrCAM mutant lacking all
Ig domains (DIg1-6 NrCAM) and one lacking all FnIII do-
mains (DFn1-5 NrCAM) were constructed. Binding assays
with axonin-1–conjugated Covaspheres revealed equal
binding to cells expressing DFn1-5 NrCAM and wild-type
NrCAM. However, no interaction was found with DIg1-6
NrCAM–expressing cells (Fig. 8 a). Thus, the axonin-1
binding site is located within the Ig domains of NrCAM.
For further analysis of the binding domains, we generated
NrCAM mutants lacking two Ig domains based on the ob-
Figure 7. NrCAM and axonin-1 undergo a trans-interaction. A heterophilic trans-interaction between axonin-1 and NrCAM was dem-
onstrated in a cell aggregation assay. Myeloma cells were stably transfected with either NrCAM, NgCAM, or axonin-1. Cells were la-
beled with different intracellular dyes and incubated as described in Materials and Methods. NrCAM-expressing (red, labeled Nr(r))
and axonin-1–expressing myeloma cells (green, labeled ax (g)) formed large mixed aggregates, demonstrating a heterophilic trans-inter-
action between axonin-1 and NrCAM (a). Homophilic trans-interactions were observed for NrCAM (b), axonin-1 (c), and NgCAM (d).
Wild-type cells (wt), i.e., nontransfected myeloma cells, did not form aggregates (e). A quantitative analysis of the aggregation assays is
given in f. The length of the bars represents the percentage of cells found in aggregates (6SD). The subdivision of the bars reflects the
ratio of the two cell populations. The red part of the bar represents the first molecule (labeled in red) and the green part represents the
second molecule (labeled in green). The small contribution of wild-type cells (10–14%) in the wt-Nr and wt-ax combinations indicates
an unspecific incorporation of wild-type cells in either homophilic NrCAM or axonin-1 aggregates rather than a specific formation of
aggregates. Expression levels of NrCAM and NgCAM were estimated on Western blots (g). A dilution series (10, 5, and 2.5 ng) of puri-
fied NrCAM or NgCAM, respectively, was compared with the amount of NrCAM or NgCAM expressed in 0.5 and 0.25 3 106 myeloma
cells. The bands on the blot were quantified densitometrically for three independent experiments. Representative examples are shown.
The expression level of NrCAM was found to be sixfold lower than the level of NgCAM.The Journal of Cell Biology, Volume 149, 2000 962
Figure 8. Localization of the axonin-1–binding site on NrCAM. Wild-type and domain deletion mutants of NrCAM were transiently
expressed in COS7 cells and tested for their binding capabilities of axonin-1–conjugated Covaspheres (ax-1 beads). NrCAM-expressing
cells were identified by indirect immunofluorescence staining using a polyclonal anti-NrCAM antibody and an FITC-labeled secondary
antibody. (a) Representative examples of each experimental condition are shown using an FITC-TRITC fluorescence filter. Axonin-1
Covaspheres (TRITC) that bound to NrCAM-expressing cells (FITC) appear in yellow. (b) For each mutant, 100 intensely green-fluo-
rescing cells were analyzed per experiment. Green-fluorescing cells that bound four or more axonin-1 Covaspheres were scored as pos-
itive binding cells. Cells that did not express wild-type or mutant NrCAM were used as internal negative controls. Each column corre-
sponds to the mean percentage of binding cells (1SD) of three independent experiments. Wild-type NrCAM expressed in COS7 cells
strongly bound axonin-1 Covaspheres. When all Ig domains were deleted (DIg1-6 Nr), no axonin-1 binding was observed, whereas full
binding persisted when all FnIII type domains (DFn1-5 Nr) were deleted. From the three double domain mutants within the Ig part
(DIg12 Nr, DIg34 Nr, and DIg56 Nr), only DIg56 Nr was able to bind axonin-1 Covaspheres. As none of the single domain deletion mu-
tants DIg1 Nr, DIg2 Nr, DIg3 Nr, and DIg4 Nr bound axonin-1, these findings indicate that the first four Ig domains of NrCAM are all
necessary for axonin-1 binding. (c) Schematic representation of wild-type NrCAM and the described domain deletion mutants. NH2 ter-
mini (NH2) are on the left, and COOH termini (COOH) are on the right. Ig domains are represented by half circles and FnIII type do-
mains by rectangular boxes. The lines indicate the domain deletions.Fitzli et al. Distinct Signals for Axon Guidance and Growth 963
servation, in many IgFnIII class molecules, that some of
the folding units comprise two adjacent domains (Huber
et al., 1994; Vaughn and Bjorkman, 1996). We found that
DIg12- and DIg34 NrCAM–expressing cells did not bind
axonin-1 Covaspheres, whereas full axonin-1 binding was
found for DIg56 NrCAM (Fig. 8, a and b). Consequently,
we deleted single domains within the segment of the first
four Ig domains, either Ig1, Ig2, Ig3, or Ig4, and found that
none of these mutants was able to interact with axonin-
1–conjugated Covaspheres (Fig. 8, a and b). In summary,
the results indicate that all four NH2-terminal Ig domains
of NrCAM are involved in the binding of axonin-1.
The Four NH2-Terminal Ig Domains of Axonin-1 Are 
Necessary and Sufficient for NrCAM Binding
We further characterized the axonin-1/NrCAM interac-
tion by localizing the NrCAM binding site on axonin-1.
For this, we used the two axonin-1 domain deletion mu-
tants Ig1234 and DIg1234 described previously (Rader et
al., 1996). In Ig1234, the four NH2-terminal Ig domains
were coupled directly to the GPI anchor, and DIg1234 was
a truncated protein in which the four NH2-terminal do-
mains were deleted. Ig1234-expressing cells exhibited
strong NrCAM binding, comparable to that of cells ex-
pressing wild-type axonin-1. In contrast, no NrCAM bind-
ing was found with DIg1234 (Fig. 10 a). Thus, we con-
cluded that the location of the binding site for NrCAM
was on the segment composed of the first four Ig domains.
Based on extensive domain deletion studies of axonin-1
and the recently concluded resolution of the spatial struc-
ture of the Ig1-4 segment of axonin-1 (Freigang et al.,
2000), the four NH2-terminal Ig domains of axonin-1 form
a structural entity that can maintain its structural and func-
tional integrity only in the presence of all four domains
(Rader et al., 1996). Therefore, attempts towards a finer
localization of the NrCAM binding site were not made.
The NrCAM and NgCAM Binding Sites on Axonin-1 
Are Overlapping but Not Identical
The four NH2-terminal Ig domains of axonin-1 previously
have been identified as the binding site for NgCAM
(Rader et al., 1996). To determine the location of the bind-
ing sites of NrCAM and NgCAM relative to each other,
we carried out perturbation experiments with a selection
of mAbs directed to the four NH2-terminal Ig domains of
axonin-1 (Rader et al., 1996). Transiently transfected COS7
cells expressing wild-type axonin-1 were incubated with
the different mAbs before the addition of the NrCAM-
coated Covaspheres. The same mAbs were subsequently
tested for their ability to block NgCAM binding to axonin-1.
An axonin-1 mutant lacking the fifth Ig domain (DIg5
axonin-1) was used for NgCAM binding studies, since it
had been shown that binding of NgCAM-Covaspheres to
membrane-bound axonin-1 strongly increased upon de-
letion of either the fifth or sixth Ig domain of axonin-1
(Fig. 10 a; Rader et al., 1996). In contrast, no difference of
NrCAM binding to wild-type compared with DIg5 axonin-1
was observed (Fig. 10 a). mAb DIg1 specifically blocked
NrCAM, but not NgCAM binding to axonin-1, whereas
mAb NIg1 blocked binding of both NrCAM and NgCAM
(Fig. 10 b). The mAb X9H8, which blocks NgCAM bind-
ing (Rader et al., 1996), did not interfere with NrCAM
binding (Fig. 10 b). These results indicate that the NrCAM
and NgCAM binding sites on axonin-1 are distinct, but are
either close together or overlapping.
Discussion
We have shown that the interaction of growth cone axo-
nin-1 with NrCAM in an appropriate substratum combina-
tion in vitro (Fig. 11 b) or expressed by floor-plate cells in
vivo (Fig. 11 d) elicits a guidance response of commissural
axons without affecting axon extension (Fig. 11, a and c).
The instructive signal allows the growth cone to discrimi-
nate between two alternative pathways with equal growth-
promoting capacities.
The Choice between Two Equally Potent
Growth-promoting Substrata Involves a Discriminatory 
Mechanism Activating an Instructive Signal
Commissural axons on alternating stripes of NrCAM/
NgCAM and NgCAM substratum exhibited a clear pref-
erence for the mixed substratum. The preferred growth on
NrCAM/NgCAM stripes was not due to a higher growth-
promoting activity, as measurements of neurite length re-
Figure 9. Analysis of the mo-
lecular masses of wild-type
NrCAM and NrCAM domain
deletion mutants. To check
the molecular masses and to
assess the expression levels of
the different mutant NrCAM
proteins, COS7 cells were
transfected by electropora-
tion and cultivated for 48 h. The solubilized proteins were ana-
lyzed by immunoblotting using a polyclonal anti-NrCAM anti-
body. The bands for wild-type NrCAM were as expected: a weak
band of z200 kD, corresponding to the small proportion of un-
cleaved protein; an intense double band of 125/135 kD, repre-
senting the fragment comprising all Ig domains and two and a
half FnIII domains; and a third intense band of 80 kD, corre-
sponding to the COOH-terminal rest of the protein. This 80-kD
fragment and two additional bands of variable molecular mass
(corresponding to the uncleaved protein and the cleaved extra-
cellular fragment) were observed in all domain deletion mutants
except for DFn1-5 NrCAM. This mutation lacks all FnIII do-
mains and, thus, also lacks the cleavage site. The molecular
masses of the uncleaved proteins of the different single and dou-
ble domain deletion mutants were z175 and 160 kD, respec-
tively. No differences among the single domain mutants and the
double domain mutants were detectable. However, more varia-
tion was found among the molecular masses of the cleaved extra-
cellular fragments. It is possible that these differences were due
to a variability of the better resolution of the gel for lower molec-
ular masses. Interestingly, we found that the proportion of un-
cleaved and cleaved protein varied strongly between the differ-
ent single and double domain deletion mutants. All mutants
lacking either the third or the fourth Ig domain (DIg3 NrCAM,
DIg4 NrCAM, and DIg34 NrCAM) displayed an unusually high
portion of uncleaved protein and relatively high molecular
masses for the large extracellular fragment.The Journal of Cell Biology, Volume 149, 2000 964
vealed that the combination of NrCAM and NgCAM did
not enhance neurite outgrowth compared with NrCAM
or NgCAM alone. Complementary to this observation,
we found that the preference-generating process can be
blocked without a decrease in neurite length. The same
anti–axonin-1 antibodies that abolished preference for the
mixed NrCAM/NgCAM substratum did not interfere with
neurite growth. Thus, we concluded that the preference-
generating effect of the axonin-1/NrCAM interaction is
not mediated via enhancing neurite outgrowth on the
mixed NrCAM/NgCAM substratum, but rather represents
an instructive guidance signal, by which the growth cones’
response is changed in favor of one substratum and against
the other.
The conclusions drawn from the in vitro assays were
tested in a series of in vivo perturbation assays of commis-
Figure 10. Localization of the NrCAM-binding site on axonin-1. To localize the binding site of NrCAM on axonin-1, mutant and wild-
type axonin-1 were transiently expressed in COS7 cells. Covaspheres coated with NrCAM (left) or NgCAM (right) bound to COS7 cells
are shown in a. (first row) Only NrCAM but not NgCAM Covaspheres bind to the COS7 cells expressing wild-type axonin-1 (ax-1
cells). Both types of Covaspheres were found to bind to the COS7 cells expressing an axonin-1 mutant lacking the fifth Ig domain (DIg5
ax-1 cells, second row), but not to cells expressing a mutant lacking the Ig domains 1–4 (DIg1234, third row). The first four Ig domains
(Ig1234) were sufficient to bind both types of Covaspheres (fourth row). COS7 cells expressing wild-type or mutant axonin-1 were visu-
alized by indirect immunofluorescence using a polyclonal rabbit anti–axonin-1 serum and Texas red–conjugated donkey anti–rabbit
IgG. The binding site of NgCAM on axonin-1 was mapped to the conglomerate formed by the first four Ig domains of axonin-1 by
Rader et al. (1996). The same axonin-1 mutants used here showed that the binding site for NrCAM is also localized on the first four Ig
domains. (b) Because NgCAM-Covaspheres did not bind to COS7 cells expressing wild-type axonin-1, we used COS7 cells expressing
the DIg5 variant of axonin-1 to compare NrCAM- and NgCAM-Covaspheres binding after incubation of the cells with the different
mAbs. Antibody DIg1, which recognizes an epitope on the first Ig domain of axonin-1, blocked binding of NrCAM- but not NgCAM-
Covaspheres (second row). The antibody NIg1, which recognizes a different epitope on the first Ig domain of axonin-1, blocked binding
of both types of Covaspheres (third row), whereas X9H8, which recognizes an epitope formed by the Ig domains 1–4, blocked only the
binding of NgCAM- but not NrCAM-Covaspheres (fourth row). In perturbation experiments with the mAbs against axonin-1, COS7
cells expressing wild-type or mutant axonin-1 were visualized by indirect immunofluorescence using Cy3-conjugated donkey anti–
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sural axons. Obviously, a choice in an in vitro system can-
not be the same as the choice in vivo, where a complex en-
vironment provides a variety of possible interactions.
Furthermore, the floor plate does not express NgCAM.
However, the two choice situations bear in common that
an interaction between growth cone axonin-1 and substra-
tum NrCAM is an essential element in the observed pref-
erence reaction. Therefore, we found it appropriate to test
whether the axonin-1/NrCAM interaction had the charac-
ter of an instructive signal without affecting axon growth
also at this well characterized choice point in vivo. Indeed,
we found that the effect of axonin-1 in commissural axon
guidance was independent of axon elongation. Both NrCAM
and NgCAM have neurite outgrowth-promoting activities
that are equivalent and redundant. Masking either NrCAM
or NgCAM alone did not decrease neurite elongation.
However, if both NrCAM- and NgCAM-derived growth
signals were abolished by concomitant injection of anti-
NrCAM and anti-NgCAM antibodies, neurite growth in
the longitudinal axis was strongly inhibited (Fig. 6, a and
e). Consistent with the hypothesis that axonin-1 mediates
a guidance signal for commissural axons without promot-
ing their growth, the injection of anti–axonin-1 together
with either anti-NgCAM (Fig. 6 c) or anti-NrCAM anti-
bodies (Fig. 6 d) did not reduce neurite length. In both
cases, neurites extended along the longitudinal axis over
the same distance as neurites in control embryos, although
a significant proportion of the axons committed pathfind-
ing errors and extended along the ipsilateral rather than
the contralateral border of the floor plate. When NgCAM
is masked (Stoeckli and Landmesser, 1995) or the mam-
malian homologue L1 is inactivated (Cohen et al., 1998),
no effect on commissural axon guidance in the spinal cord
was found, which is consistent with the idea that NrCAM
would still be able to provide a signal for growth and for
guidance.
Based on these results, we concluded that the floor plate
and the longitudinal tract display their full growth-pro-
moting activities for commissural axons also in the ab-
sence of axonin-1/NrCAM interactions. Therefore, the
guidance instruction given to the commissural growth
cones by the axonin-1/NrCAM interaction in vivo is medi-
ated by a mechanism distinct from axon growth promo-
tion. This result is interesting in light of recent findings
published by Lustig et al. (1999), demonstrating that axo-
nin-1 is the axonal receptor mediating neurite outgrowth
from peripheral ganglia on an NrCAM substratum. Obvi-
ously, the contributions of individual CAMs to neurite
growth and guidance are context dependent. Whereas an
individual CAM can be involved in growth promotion in
one neuronal population, it is mediating a guidance signal
without influencing neurite extension in another situation.
Thus, whereas axonin-1 is providing an instructive guid-
ance signal for commissural axons, without affecting axon
extension, NrCAM is involved in both axon guidance (via
interaction with growth cone axonin-1) and axon growth
(via interaction with an unknown growth cone receptor;
Fig. 11). NgCAM is involved in neurite extension only
without affecting guidance. Because L1, the mouse homo-
logue of chicken NgCAM, was shown to have an effect on
pathfinding of corticospinal axons (Cohen et al., 1998), the
role of CAMs has to be characterized in detail for every
neuronal population.
In summary, the results of the present study demon-
strate that in vivo and in vitro signals for guidance are dis-
tinct from signals for growth. However, the distinction be-
tween growth and guidance is not a characteristic function
associated with a particular CAM, but rather reflects the
role of a CAM in the context of a specific neuronal popu-
lation.
The Enlargement of the Growth Cones in Our In Vitro 
Assay Correlates with In Vivo Observations of Growth 
Cone Size at Choice Points
The growth cones expressing a preference in our in vitro
Figure 11. An axonin-1/NrCAM interaction is crucial for guid-
ance of commissural axons, but is not involved in their growth
promotion. Based on our in vitro and in vivo studies, we conclude
that an axonin-1/NrCAM interaction is crucial for guidance but
not for the growth of commissural axons. Axon guidance is not
achieved via the selection of the most growth-promoting substra-
tum, but it depends on an instructive signal to the growth cone
that is mediated by axonin-1. a and c summarize our results show-
ing that neurite extension is independent of axonin-1 both in
vitro (a) as well as in vivo (c). In both situations, axon extension
is mediated by the interaction of an unknown growth cone recep-
tor with NrCAM and NgCAM. The growth-promoting signals
derived from NrCAM and NgCAM appear to be redundant, as
neurite lengths were the same on an NrCAM, an NgCAM, and a
mixed NrCAM/NgCAM substratum. Most importantly, neurite
length on all substrates tested was independent of the presence
or absence of anti–axonin-1 antibodies. b and d summarize our
results demonstrating a crucial role of axonin-1 in axon guidance
both in vitro (b) and in vivo (d). The presence of anti–axonin-1
antibodies abolished the preference of commissural growth cones
for the mixed NrCAM/NgCAM substratum in our stripe assay
(b) without decreasing neurite length. Similarly, after injection of
anti–axonin-1 antibodies, commissural axons failed to cross the
floor plate without exhibiting any decrease in their growth capac-
ity. Although the molecular interactions in vivo are far more
complex than the situation mimicked in our in vitro assay, the
choice of commissural axons to grow on the mixed NrCAM/Ng-
CAM substratum (b) and to grow across the midline by entering
the floor plate in vivo (d) have in common that axonin-1 is the
key molecule triggering the growth cone’s decision.The Journal of Cell Biology, Volume 149, 2000 966
choice assays were approximately twice as large as the
ones not expressing a preference (294 versus 145 mm2).
The growth cone size was not determined by the substra-
tum alone. Among the growth cones on mixed NrCAM/
NgCAM, the enlarged phenotype was assumed only by
those that had chosen NrCAM/NgCAM versus alternating
NgCAM and, thus, showed the preference reaction. Growth
cones on homogeneously coated NrCAM/NgCAM or on
NrCAM/NgCAM stripes alternated with NrCAM were
not enlarged. The growth cone enlargement was also not
found on alternating stripes of NrCAM/NgCAM and
NgCAM, when the preference was abolished by the pres-
ence of anti–axonin-1 antibodies. The strict coincidence of
growth cone enlargement and preference reaction sug-
gests that the two phenomena are functionally connected.
Concurrent conclusions were drawn from observations in
vivo, where morphological changes of growth cones react-
ing to particular choice points along their path have been
described in fixed and living tissue (Godement et al., 1994;
Mason and Wang, 1997). Whereas growth cones have a
simple morphology while they are advancing along fiber
tracts, they assume a more complex shape at choice points,
such as the optic chiasm (Godement et al., 1994; Mason
and Wang, 1997) and the floor plate (Bovolenta and
Dodd, 1990). In line with our observations in vitro, where
growth cone enlargement was strictly correlated with a de-
cision for one substratum and against the other, growth
cone size was shown to be much larger for growth cones in
the floor plates, the decision region, compared with the ip-
silateral neuroepithelium (Bovolenta and Dodd, 1990).
Binding of Axonin-1 to NrCAM Can only Be 
Established when Axonin-1 Is Not Bound to NgCAM
The substratum combination that was found to elicit a
preference/enlargement response in commissural axons in
vitro is distinct from the not yet known substratum com-
bination determining their pathway choice in vivo. How-
ever, the two reactions have a common denominator. In
both situations, a trans-interaction of growth cone axonin-1
and substratum NrCAM is an essential element in the
initiation of the preference response. Moreover, in both
situations, the interruption of the axonin-1/NrCAM inter-
action abolishes the preference and results in an indiscrim-
inate growth on the available substrata.
The preference-generating interaction between growth
cone axonin-1 and substratum NrCAM is one of several
possible interactions for both axonin-1 and NrCAM. Axo-
nin-1 has been shown to undergo a homophilic trans-inter-
action (Rader et al., 1993) and to form a cis-interaction
with NgCAM (Buchstaller et al., 1996). NrCAM interacts
homophilicly (Mauro et al., 1992) and heterophilicly with
F11 in trans (Morales et al., 1993; Volkmer et al., 1996). In
addition, several other ligands have been identified for
both, with unknown cellular topology (for reviews see Gru-
met, 1997; Sonderegger, 1997). With myeloma cells ex-
pressing axonin-1 or NrCAM we have demonstrated that
axonin-1 and NrCAM establish a strong trans-interaction
across the intercellular space. This is in contrast to the in-
teraction between axonin-1 and NgCAM, which is only es-
tablished between molecules located in the same mem-
brane (Buchstaller et al., 1996). Using the same domain
deletion approach as previously for NgCAM (Kunz et al.,
1998), the axonin-1–binding site of NrCAM was localized
on the first four Ig domains. Studies with truncated forms
of axonin-1 revealed that the binding site for NrCAM is
located on the domain conglomerate formed by the first
four Ig domains. The same location was previously found
for the binding site of NgCAM (Rader et al., 1996). In the
same study, evidence suggested that monomeric wild-type
axonin-1 is bent back at a hinge located in the middle of
the molecule giving it a horseshoelike structure. Because
of this structure, the conglomerate of NgCAM-binding
domains is located close to the membrane and binding of
NgCAM across the extracellular space would not be possi-
ble. An axonin-1 mutant that lacks the fifth Ig domain and,
therefore, is thought to have an extended structure, binds
NgCAM presented on the surface of Covaspheres (Rader
et al., 1996). In contrast, we found that strong binding of
NrCAM was observed with both cells expressing wild-type
and mutant axonin-1 lacking the fifth Ig domain. We con-
cluded that NrCAM can bind axonin-1 across the extra-
cellular space regardless whether it is presented in a
horseshoelike or in an extended conformation. Thus, the
topological requirements for axonin-1 for the axonin-1/
NrCAM interaction are clearly distinct from those needed
for the axonin-1/NgCAM interaction. The relative loca-
tion of the binding sites for NrCAM and NgCAM on the
conglomerate of domains Ig1-4 of axonin-1 was addressed
by a perturbation study with mAbs. Based on the results,
we concluded that the binding areas for NrCAM and
NgCAM on the conglomerate of domains Ig1–4 of axo-
nin-1 are distinct, but overlapping, and may result in a mu-
tual exclusion for axonin-1/NrCAM and axonin-1/NgCAM
binding.
The establishment of an axonin-1/NrCAM interaction at
the expense of an axonin-1/NgCAM cis-interaction could
generate the intracellular signals regulating the directional
growth of the growth cone at the floor-plate border. The
molecular mechanism by which the axonin-1/NrCAM in-
teraction generates preference in growth cones that are in
contact with NgCAM and NrCAM is at present not
known. We have previously found that intracellular signal-
ing of axonin-1 changes depending on its interactions.
Analyses of kinases associated with axonin-1 and NgCAM
revealed that monomeric axonin-1 is associated with the
tyrosine kinase fyn, whereas monomeric NgCAM is asso-
ciated with a casein kinase II (Kunz et al., 1996). In low
density cultures without neurite–neurite contacts, the axo-
nin-1–associated fyn activity was high and the NgCAM-
associated casein kinase II activity was low. When neurites
formed fascicles, axonin-1 and NgCAM were found in in-
creasing quantities as heterodimeric and heterotetrameric
complexes. The formation of these complexes at the sites
of neuritic membrane contacts in the fascicles was accom-
panied by a switch in intracellular signaling. The signals as-
sociated with axonin-1 and NgCAM changed in the oppo-
site direction. Axonin-1–associated fyn was reduced and
NgCAM-associated kinases were increased. Based on ob-
servations that tubulin polymerization correlates with ty-
rosine phosphorylation (Thomas et al., 1995), and that a
stabilization of microtubules correlates with phosphoryla-
tion of MAP1B by casein kinase II (Ulloa et al., 1993), we
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between different neurites in fascicles might be achieved
via a decrease in fyn activity and an increase in the activity
of the NgCAM-associated kinases. It is possible that the
binding of growth cone axonin-1 with floor-plate NrCAM
reverses the dimerization of axonin-1 with NgCAM, and,
thus, its integration into heterotetrameric complexes. This
could result in the flexibility of commissural axons to
make their turns at both floor-plate entry and exit sites.
Conclusions
Growth cones at choice points decide for a particular path-
way and against another based on molecular interactions
between growth cone receptors and molecular cues en-
countered at the choice point. Our observations in vitro
and in vivo provide evidence that, for commissural axons,
the growth cone receptor mediating correct guidance is ax-
onin-1. In both the in vitro model and the in vivo situation,
the interaction between growth cone axonin-1 and sub-
stratum NrCAM is not involved in axon elongation, but
provides the decision making guidance signal, resulting in
the preference for one pathway. Growth cones show a
marked enlargement dependent on the preference reac-
tion rather than on the substratum both in vitro and in
vivo. Although our in vitro model for a choice point for
commissural axons is highly simplified using only two se-
lected molecules, NrCAM and NgCAM, as substrata, it
exhibits characteristic features associated with the deci-
sion of commissural axons at the floor plate in vivo, and,
therefore, may be an excellent model for future studies of
the molecular mechanisms that determine the growth
cone’s decisions at choice points.
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